Sonoma Pharmaceuticals
SNOA
19 hedge funds and large institutions have $3.62M invested in Sonoma Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 4 closing their positions.
1,104% more capital inflows, than outflows
Capital inflows: $1.23M | Capital outflows: $102K
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
3.3% more ownership
Funds ownership: 8.56% → 11.86% (+3.3%)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
10% less funds holding
Funds holding: 21 → 19 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JW Asset Management
Miami Beach,
Florida
|
+$652K |
| 2 |
Renaissance Technologies
New York
|
+$200K |
| 3 |
BlackRock
New York
|
+$178K |
| 4 |
Virtu KCG Holdings
New York
|
+$84.9K |
| 5 |
Janus Henderson Investors US
Denver,
Colorado
|
+$72.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$53K |
| 2 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$18.6K |
| 3 |
Bard Associates
Chicago,
Illinois
|
-$17.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$5.81K |
| 5 |
Advisor Group
Phoenix,
Arizona
|
-$5K |
SNOA Hedge Fund Activity: Q1 2017 in Review
19 of the 4,035 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q1 2017, worth a combined $3.62M — up 99% from $1.82M a quarter earlier.
Fund positioning in SNOA was balanced in Q1 2017: 4 funds opened new positions, 4 closed out, 7 added to existing stakes and 3 trimmed.
The largest buyer was JW Asset Management, opening a new position worth an estimated $652K. The largest seller was B. Riley Wealth Advisors, exiting entirely with an estimated $53K sold.
- 19 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q1 2017, down from 21 in Q4 2016.
- Funds reported $3.62M of Sonoma Pharmaceuticals stock for Q1 2017, up 99% quarter-over-quarter.
- 4 funds opened new Sonoma Pharmaceuticals positions in Q1 2017 and 4 closed out, a net change of 0 holders.
- The largest Sonoma Pharmaceuticals buyer in Q1 2017 was JW Asset Management, an estimated $652K added.
- The largest Sonoma Pharmaceuticals seller in Q1 2017 was B. Riley Wealth Advisors, an estimated $53K sold.
Based on aggregated 13F filings for Q1 2017.